Deanna Harshbarger, Cala Health’s CEO, brings over two decades of experience and leadership in the global medical device space, having the ideal blend of expertise across the entire business continuum, from early product development to successful commercialization in movement disorders, neuromodulation and durable medical equipment (DME). Deanna successfully led the oversubscribed commercial funding raise for Cala. Prior to her most recent role as chief product officer at Cala, Deanna served in leadership positions at Medtronic Diabetes, Boston Scientific Neuromodulation and Johnson & Johnson, focused on building businesses, developing winning portfolios, and guiding strategic business development acquisitions. Deanna holds an MBA from the Kellogg School of Management at Northwestern University and a BS in Chemical Engineering from Case Western Reserve University.